In vivo trial assesses bone healing effect of 3D-printed scaffolds in Wistar rats, indicating potential for treatment.
The present study investigated the effect of a 3D-printed nanocomposite scaffold on bone healing in vivo. The scaffolds used were made from the bioresorbable thermoplastic polycaprolactone polymer, blended with Multi-Walled Carbon Nanotubes functionalized with chitosan, and manufactured with a rectilinear infill pattern and interconnected pores of 500 μm in size. The study included three groups of 10 Wistar rats, in which a 2 mm bone defect was created in the middle of the right femur. In the scaffold/peptide group, the gap was filled with the scaffold loaded with a peptide corresponding to human pleiotrophin amino acids 48-56 (PTN48-56), and the fracture was stabilized with a 12 mm K-wire as an intramedullary nail. In the scaffold group, the scaffold did not contain the peptide, and in the control group, the bone defect was stabilized without the use of a scaffold. Radiological examination revealed that bone healing was achieved on average in 6.6 weeks in the scaffold/peptide group, 7.2 weeks in the scaffold group, and 8.1 weeks in the control group. Histopathological examination performed 2 weeks postoperatively showed that angiogenesis in the scaffold/peptide group was 1.5 times higher than in the scaffold group and 2.5 times higher than in the control group. In conclusion, our osteo-inductive 3D-printed scaffold covered with PTN48-56 is a promising option for accelerating bone defect healing.
No takes yet. Share an insight, caveat, or question.
Tsoumanis et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: